| pubmed-article:6145120 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6145120 | lifeskim:mentions | umls-concept:C0037659 | lld:lifeskim |
| pubmed-article:6145120 | lifeskim:mentions | umls-concept:C0007412 | lld:lifeskim |
| pubmed-article:6145120 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6145120 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6145120 | pubmed:dateCreated | 1984-7-9 | lld:pubmed |
| pubmed-article:6145120 | pubmed:abstractText | Somatostatin and several analogues were injected into rat striatum and their effects on dopamine, serotonin and their metabolites were examined at 1 h. Somatostatin induced a dose-dependent increase in dopamine turnover in the ipsilateral striatum accompanied by a reduction in turnover on the contralateral side. There was no effect on serotonin turnover. Long-acting somatostatin analogues (D-Trp-8-somatostatin, SMS-201-995) had similar effects. These results suggest that somatostatin is involved in local regulation of striatal dopaminergic transmission and that it plays a role in regulation of dopamine release in the contralateral striatum. | lld:pubmed |
| pubmed-article:6145120 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145120 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6145120 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145120 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6145120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145120 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6145120 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6145120 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:6145120 | pubmed:issn | 0304-3940 | lld:pubmed |
| pubmed-article:6145120 | pubmed:author | pubmed-author:MartinJ BJB | lld:pubmed |
| pubmed-article:6145120 | pubmed:author | pubmed-author:BealM FMF | lld:pubmed |
| pubmed-article:6145120 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6145120 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:6145120 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:6145120 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6145120 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6145120 | pubmed:pagination | 271-6 | lld:pubmed |
| pubmed-article:6145120 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:meshHeading | pubmed-meshheading:6145120-... | lld:pubmed |
| pubmed-article:6145120 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6145120 | pubmed:articleTitle | The effect of somatostatin on striatal catecholamines. | lld:pubmed |
| pubmed-article:6145120 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6145120 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6145120 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6145120 | lld:pubmed |
